DÄ internationalArchive33-34/2019Functional somatic symptoms

Clinical Practice Guideline

Functional somatic symptoms

Dtsch Arztebl Int 2019; 116: 553-60. DOI: 10.3238/arztebl.2019.0553

Roenneberg, C; Sattel, H; Schaefert, R; Henningsen, P; Hausteiner-Wiehle, C

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

*Alle Herausgeber, Autoren und Bearbeiter der Leitlinie werden im eKasten 1 aufgelistet.
Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Klinikum rechts der Isar der Technischen Universität München: Dr. med. Casper Roenneberg, MHBA; Dipl.-Psych. Heribert Sattel, Prof. Dr. med. Peter Henningsen, Prof. Dr. med. Constanze Hausteiner-Wiehle
Klinik für Psychosomatik, Universität und Universitätsspital, Basel: Prof. Dr. med. Rainer Schaefert
Klinik für Allgemeine Innere Medizin und Psychosomatik, Universitätsklinikum Heidelberg:
Prof. Dr. med. Rainer Schaefert
BG Unfallklinik Murnau, Psychosomatik/Neurozentrum, Murnau:
Prof. Dr. med. Constanze Hausteiner-Wiehle
1.Hausteiner-Wiehe C, Henningsen P, Häuser W, et al.: Umgang mit Patienten mit nicht-spezifischen, funktionellen und somatoformen Körperbeschwerden. S3-Leitlinie mit Quellentexten, Praxismaterialien und Patientenleitlinie. Stuttgart: Klett-Cotta (vormals Schattauer) 2013 1 ff.
2.Schaefert R, Hausteiner-Wiehle C, Hauser W, Ronel J, Herrmann M, Henningsen P: Non-specific, functional, and somatoform bodily complaints. Dtsch Arztebl Int 2012; 109: 803–13 CrossRef MEDLINE PubMed Central
3.S3-Leitlinie „Funktionelle Körperbeschwerden“. www.awmf.org/leitlinien/detail/ll/051-001.html (last accessed on 4 March 2019).
4.Henningsen P, Zipfel S, Sattel H, Creed F: Management of functional somatic syndromes and bodily distress. Psychother Psychosom 2018; 87: 12–31 CrossRef MEDLINE
5.Hausteiner-Wiehle C, Henningsen P: Kein Befund und trotzdem krank? Stuttgart: Klett-Cotta (vormals Schattauer) 2015 CrossRef
6.Henningsen P, Martin A: Somatoforme Störungen, somatische Belastungsstörung. In: Herpertz S, Caspar F, Lieb K, eds.:. Psychotherapie. Funktions- und störungsorientiertes Vorgehen. München: Elsevier 2016 CrossRef
7.van Gils A, Schoevers RA, Bonvanie IJ, Gelauff JM, Roest AM, Rosmalen JG: Self-help for medically unexplained symptoms: a systematic review and meta-analysis. Psychosom Med 2016; 78: 728–39 CrossRef MEDLINE
8.van Dessel N, den Boeft M, van der Wouden JC, et al.: Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev 2014; (11): CD011142 CrossRef
9.Larun L, Brurberg KG, Odgaard-Jensen J, Price JR: Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev 2016; (2): CD003200 CrossRef MEDLINE
10.Winkelmann A, Häuser W, Friedel E, et al.: Physiotherapy and physical therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline. Schmerz 2012; 26: 276–86 CrossRef MEDLINE
11.Arnold B, Häuser W, Arnold M, et al.: Multimodale Therapie des Fibromyalgiesyndroms. Systematische Übersicht, Metaanalyse und Leitlinie. Schmerz 2012; 26: 287–90 CrossRef MEDLINE
12.Häuser W, Wolfe F, Tölle T, Uçeyler N, Sommer C: The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 2012; 26: 297–307 CrossRef MEDLINE
13.Walitt B, Urrútia G, Nishishinya MB, Cantrell SE, Häuser W: Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Database Syst Rev 2015; (6): CD011735 CrossRef MEDLINE PubMed Central
14.Cording M, Derry S, Phillips T, Moore RA, Wiffen PJ: Milnacipran for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2015; (10): CD008244 CrossRef MEDLINE PubMed Central
15.Derry S, Cording M, Wiffen PJ, Law S, Phillips T, Moore RA: Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst Rev 2016; 9: CD011790 CrossRef PubMed Central
16.Li YH, Wang FY, Feng CQ, Yang XF, Sun YH: Massage therapy for fibromyalgia: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2014; 9: e89304 CrossRef MEDLINE PubMed Central
17.Yuan QL, Wang P, Liu L, et al.: Acupuncture for musculoskeletal pain: a meta-analysis and meta-regression of sham-controlled randomized clinical trials. Sci Rep 2016; 6: 30675 CrossRef MEDLINE PubMed Central
18.Bernardy K, Klose P, Busch AJ, Choy EH, Häuser W: Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev 2013; (9): CD009796 CrossRef PubMed Central
19.Lauche R, Cramer H, Dobos G, Langhorst J, Schmidt S: A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J Psychosom Res 2013, 75: 500–10 CrossRef MEDLINE
20.Chao GQ, Zhang S: Effectiveness of acupuncture to treat irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2014; 20: 1871–7 CrossRef MEDLINE PubMed Central
21.Manheimer E, Cheng K, Wieland LS, et al.: Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2012; (5): CD005111 CrossRef PubMed Central
22.Aucoin M, Lalonde-Parsi MJ, Cooley K: Mindfulness-based therapies in the treatment of functional gastrointestinal disorders: a meta-analysis. Evid Based Complement Alternat Med 2014; 2014: 140724 CrossRef MEDLINE PubMed Central
23.Laird KT, Tanner-Smith EE, Russell AC, Hollon SD, Walker LS: Short-term and long-term efficacy of psychological therapies for irritable bowel syndrome: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14: 937–47 CrossRef MEDLINE
24.Ford AC, Quigley EM, Lacy BE, et al.: Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2014; 109: 1350–65 CrossRef MEDLINE
25.Schaefert R, Klose P, Moser G, Häuser W: Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis. Psychosom Med 2014; 76: 389–98 CrossRef MEDLINE
26.Chang L, Lembo A, Sultan S: American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome. Gastroenterology 2014; 147: 1149–72.e2 CrossRef MEDLINE
27.Li J, Zhu W, Liu W, Wu Y, Wu B: Rifaximin for irritable bowel syndrome: a meta-analysis of randomized placebo-controlled trials. Medicine (Baltimore) 2016; 95: e2534 CrossRef MEDLINE PubMed Central
28.Deutsche Schmerzgesellschaft. Definition, Pathophysiologie, Diagnostik und Therapie des Fibromyalgiesyndroms. www.awmf.org/leitlinien/detail/ll/145-004.html (last accessed on 22 February 2019).
29.Bundes­ärzte­kammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Nicht-spezifischer Kreuzschmerz – Kurzfassung, 2nd edition. Version 1. 2017 (last accessed on 22 February 2019).
30.Martin A, Härter M, Henningsen P, Hiller W, Kröner-Herwig B, Rief W: Evidenzbasierte Leitlinie zur Psychotherapie somatoformer Störungen und assoziierter Syndrome (Vol. 4). Göttingen: Hogrefe Verlag 2013.
e1.Hilderink PH, Collard R, Rosmalen JG, Oude Voshaar RC: Prevalence of somatoform disorders and medically unexplained symptoms in old age populations in comparison with younger age groups: a systematic review. Ageing Res Rev 2013; 12: 151–6 CrossRef MEDLINE
e2.Nimnuan C, Hotopf M, Wessely S: Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001; 51: 361–7 CrossRef
e3.Maiden NL, Hurst NP, Lochhead A, Carson AJ, Sharpe M: Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology (Oxford) 2003; 42: 108–12 CrossRef MEDLINE
e4.Snijders TJ, de Leeuw FE, Klumpers UM, Kappelle LJ, van Gijn J: Prevalence and predictors of unexplained neurological symptoms in an academic neurology outpatient clinic—an observational study. J Neurol 2004; 251: 66–71 CrossRef MEDLINE
e5.de Waal MW, Arnold IA, Eekhof JA, van Hemert AM: Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry 2004; 184: 470–6 CrossRef MEDLINE
e6.Verhaak PF, Meijer SA, Visser AP, Wolters G: Persistent presentation of medically unexplained symptoms in general practice. Fam Pract 2006; 23: 414–20 CrossRef MEDLINE
e7.Rosendal M, Olde Hartman TC, Aamland A, et al.: „Medically unexplained“ symptoms and symptom disorders in primary care: prognosis based recognition and classification. BMC Fam Pract 2017; 18: 18 CrossRef MEDLINE PubMed Central
e8.Lieb R, Zimmermann P, Friis RH, Höfler M, Tholen S, Wittchen HU: The natural course of DSM-IV somatoform disorders and syndromes among adolescents and young adults: a prospective longitudinal community study. Eur Psychiatry 2002; 17: 321–3 CrossRef
e9.Jackson JL, Kroenke K: Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow up study. Psychosom Med 2008; 70: 430–4 CrossRef MEDLINE
e10.Steinbrecher N, Hiller W: Course and prediction of somatoform disorder and medically unexplained symptoms in primary care. Gen Hosp Psychiatry 2011; 33: 318–26 CrossRef MEDLINE
e11.Olde Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van Weel C: Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res 2009; 66: 363–77 CrossRef MEDLINE
e12.Budtz-Lilly A, Vestergaard M, Fink P, Carlsen AH, Rosendal M: The prognosis of bodily distress syndrome: a cohort study in primary care. Gen Hosp Psychiatry 2015; 37: 560–6 CrossRef MEDLINE
e13.Wiborg JF, Gieseler D, Fabisch AB, Voigt K, Lautenbach A, Löwe B: Suicidality in primary care patients with somatoform disorders. Psychosom Med 2013; 75: 800–6 CrossRef MEDLINE
e14.Kämpfer N, Staufenbiel S, Wegener I, et al.: Suicidality in patients with somatoform disorder—the speechless expression of anger? Psychiatry Res 2016; 246: 485–91 CrossRef MEDLINE
e15.Lan CC, Tseng CH, Chen JH, et al.: Increased risk of a suicide event in patients with primary fibromyalgia and in fibromyalgia patients with concomitant comorbidities: a nationwide population-based cohort study. Medicine (Baltimore) 2016; 95: e5187 CrossRef MEDLINE PubMed Central
e16.Calati R, Laglaoui Bakhiyi C, Artero S, Ilgen M, Courtet P: The impact of physical pain on suicidal thoughts and behaviors: meta-analyses. J Psychiatr Res 2015; 71: 16–32 CrossRef MEDLINE
e17.Spiegel B, Schoenfeld P, Naliboff B: Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome. Aliment Pharmacol Ther 2007; 26: 183–93 CrossRef MEDLINE
e18.Wessely S, Nimnuan C, Sharpe M: Functional somatic syndromes: one or many? Lancet 1999; 354: 936–9 CrossRef
e19.Olde Hartman TC, Lucassen PL, van de Lisdonk EH, Bor HH, van Weel C: Chronic functional somatic symptoms: a single syndrome? Br J Gen Pract 2004; 54: 922–7.
e20.Henningsen P, Zimmermann T, Sattel H: Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med 2003, 65, 528–33 CrossRef PubMed Central
e21.Fink P, Toft T, Hansen MS, Ørnbøl E, Olesen F: Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom Med 2007; 69: 30–9 CrossRef MEDLINE
e22.Kanaan RA, Lepine JP, Wessely SC: The association or otherwise of the functional somatic syndromes. Psychosom Med 2007; 69: 855–9 CrossRef MEDLINE PubMed Central
e23.Riedl A, Schmidtmann M, Stengel A, et al.: Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008; 64: 573–82 CrossRef MEDLINE
e24.Fink P, Schröder A: One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res 2010; 68: 415–26 CrossRef MEDLINE
e25.Lieb R, Meinlschmidt G, Araya R: Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med 2007; 69: 860–3 CrossRef MEDLINE
e26.Lowe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K: Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008; 30: 191–9 CrossRef MEDLINE
e27.Hanel G, Henningsen P, Herzog W, et al.: Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study. J Psychosom Res 2009; 67: 189–97 CrossRef MEDLINE
e28.Kohlmann S, Gierk B, Hilbert A, Brahler E, Lowe B: The overlap of somatic, anxious and depressive syndromes: a population-based analysis. J Psychosom Res 2016; 90: 51–6 CrossRef MEDLINE
e29.Hatcher S, Gilmore K, Pinchen K: A follow-up study of patients with medically unexplained symptoms referred to a liaison psychiatry service. Int J Psychiatry Med 2011; 41: 217–27 CrossRef MEDLINE
e30.Stone J, Carson A, Duncan R, et al.: Symptoms unexplained by organic disease in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain 2009; 132: 2878–88 CrossRef MEDLINE
e31.Eikelboom EM, Tak LM, Roest AM, Rosmalen JGM: A systematic review and meta-analysis of the percentage of revised diagnoses in functional somatic symptoms. J Psychosom Res 2016; 88: 60–7 CrossRef MEDLINE
e32.Konnopka A, Schaefert R, Heinrich S, et al.: Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom 2012; 81: 265–75 CrossRef MEDLINE
e33.Rask MT, Ørnbøl E, Rosendal M, Fink P: Long-term outcome of bodily distress syndrome in primary care: a follow-up study on health care costs, work disability, and self-rated health. Psychosom Med 2017; 79: 345–57 CrossRef MEDLINE PubMed Central
e34.Oxford Centre for Evidence-Based Medicine (2009) Levels of evidence. www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/ (last accessed on 10 August 2018).
e35.Puhan MA, Schünemann HJ, Murad MH, et al.: A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ 2014; 349: g5630 CrossRef MEDLINE
e36.Beauchamp TL, Childress JF: Principles of biomedical ethics. Oxford: Oxford University Press 2013.
e37.Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF): AWMF-Regelwerk Leitlinien. www.awmf.org/leitlinien/awmf-regelwerk.html (last accessed on 31 August 2018).
e38.Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF), Ärztliches Zentrum für Qualität in der Medizin (ÄZQ), eds: Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI) – Fassung 2005/2006 + Domäne 8. www.leitlinien.de/mdb/edocs/pdf/literatur/delbi-fassung-2005-2006-domaene-8-2008.pdf (last accessed on 10 August 2018).
e39.Berens S, Hausteiner-Wiehle C, Sattel H, et al.: Schweregrad-gestuftes, kooperatives und koordiniertes Versorgungsmodell für Patienten mit nicht-spezifischen, funktionellen und somatoformen Körperbeschwerden. Psychologische Medizin: Österreichische Fachzeitschrift für medizinische Psychologie, Psychosomatik und Psychotherapie 2016; 4: 13–22.
e40.Almquist E, Toernblom H, Simreìn M: Practical management of irritable bowel syndrome: a clinical review. Minerva gastroenterologica e dietologica 2016; 62: 30–48.
e41.van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, Swinkels JA: Presentation of the multidisciplinary guideline Medically Unexplained Physical Symptoms (MUPS) and somatoform disorder in the Netherlands: disease management according to risk profiles. J Psychosom Res 2012; 72: 168–9 CrossRef MEDLINE
e42.Salmon P, Peters S, Stanley I: Patients‘ perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ 1999; 318: 372–6 CrossRef MEDLINE PubMed Central
e43.Arbeitskreis PISO (Hrsg.): Psychodynamisch-Interpersonelle Therapie bei somatoformen Störungen (PISO). Eine manualisierte Kurzzeitintervention. Göttingen: Hogrefe Verlag 2012; 47ff.
e44.Schaefert R, Bölter R, Faber R, Claudia Kaufmann C: Tangential, nicht frontal. Annäherung an eine schwierige Patientengruppe. Psychotherapie im Dialog 2008; 9: 252–9 CrossRef
e45.Rask MT, Carlsen AH, Budtz-Lilly A, Rosendal M: Multiple somatic symptoms in primary care patients: a cross-sectional study of consultation content, clinical management strategy and burden of encounter. BMC Fam Pract 2016; 17: 100 CrossRef MEDLINE PubMed Central
e46.Olde Hartman TC, Woutersen-Koch H, van der Horst HE: Medically unexplained symptoms: evidence, guidelines, and beyond. Br J Gen Pract 2013; 63: 625–6 CrossRef MEDLINE PubMed Central
e47.Brownell AK, Atkins C, Whiteley A, Woollard RF, Kornelsen J: Clinical practitioners‘ views on the management of patients with Medically Unexplained Physical Symptoms (MUPS): a qualitative study. BMJ Open 2016; 6: e012379 CrossRef MEDLINE PubMed Central
e48.Murray AM, Toussaint A, Althaus A, Lowe B: The challenge of diagnosing non-specific, functional, and somatoform disorders: a systematic review of barriers to diagnosis in primary care. J Psychosom Res 2016; 80: 1–10 CrossRef MEDLINE
e49.Deyo RA, Rainville J, Kent DL: What can the history and physical examination tell us about low back pain? JAMA 1992; 268: 760–5 CrossRef MEDLINE
e50.Pryor DB, Shaw L, McCants CB, et al.: Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993; 118: 81–90 CrossRef MEDLINE
e51.Kroenke K: A practical and evidence-based approach to common symptoms: a narrative review. Ann Intern Med 2014; 161: 579–86 CrossRef MEDLINE
e52.Evens A, Vendetta L, Krebs K, Herath P: Medically unexplained neurologic symptoms: a primer for physicians who make the initial encounter. Am J Med 2015; 128: 1059–64 CrossRef MEDLINE
e53.Kelly M, Tink W, Nixon L, Dornan T: Losing touch? Refining the role of physical examination in family medicine. Can Fam Physician 2015; 61: 1041–3.
e54.Pincus T, Holt N, Vogel S, et al.: Cognitive and affective reassurance and patient outcomes in primary care: a systematic review. Pain 2013; 154: 2407–16 CrossRef MEDLINE
e55.Mann B, Wilson H: Diagnosing somatisation in adults in the first consultation: moving beyond diagnosis by exclusion. Br J Gen Pract 2013; 63: 607–8 CrossRef MEDLINE PubMed Central
e56.Lorenzer A: Interaktion, Sprache und szenisches Verstehen. Psyche 1983: 37; 97–115.
e57.Riess H, Kraft-Todd G: E.M.P.A.T.H.Y.: a tool to enhance nonverbal communication between clinicians and their patients. Acad Med 2014; 89: 1108–12 CrossRef MEDLINE
e58.Axt-Adam P, van der Wouden JC, van der Does E: Influencing behavior of physicians ordering laboratory tests: a literature study. Med Care 1993; 31: 784–94 CrossRef
e59.van Wijk MA, van der Lei J, Mosseveld M, Bohnen AM, van Bemmel JH: Assessment of decision support for blood test ordering in primary care. a randomized trial. Ann Intern Med 2001; 134: 274–81 CrossRef MEDLINE
e60.Koch H, van Bokhoven MA, ter Riet G, et al.: Ordering blood tests for patients with unexplained fatigue in general practice: what does it yield? Results of the VAMPIRE trial. Br J Gen Pract 2009; 59: e93–100 CrossRef PubMed Central
e61.Epstein RM, Hadee T, Carroll J, Meldrum SC, Lardner J, Shields CG: “Could this be something serious?” Reassurance, uncertainty, and empathy in response to patients’ expressions of worry. J Gen Intern Med 2007; 22: 1731–9 MEDLINE
e62.Anderson M, Hartz A, Nordin T, et al.: Community physicians‘ strategies for patients with medically unexplained symptoms. Fam Med 2008; 40: 111–8.
e63.Giroldi E, Veldhuijzen W, Leijten C, et al.: ‚No need to worry‘: an exploration of general practitioners‘ reassuring strategies. BMC Fam Pract 2014; 15: 133 CrossRef MEDLINE PubMed Central
e64.Hasenbring MI, Pincus T: Effective reassurance in primary care of low back pain: what messages from clinicians are most beneficial at early stages? Clin J Pain 2015; 31: 133–6 CrossRef MEDLINE
e65.Musekamp G, Gerlich C, Ehlebracht-König I, Faller H, Reusch A: Evaluation of a self-management patient education program for patients with fibromyalgia syndrome: study protocol of a cluster randomized controlled trial. BMC Musculoskelet Disord 2016; 17: 55 CrossRef MEDLINE PubMed Central
e66.Smith RC, Lyles JS, Gardiner JC, et al.: Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med 2006; 21: 671–7 CrossRef MEDLINE PubMed Central
e67.Smith RC, Gardiner JC, Luo Z, Schooley S, Lamerato L, Rost K: Primary care physicians treat somatization. J Gen Intern Med 2009; 24: 829–32 CrossRef MEDLINE PubMed Central
e68.Aiarzaguena JM, Grandes G, Gaminde I, Salazar A, Sanchez A, Arino J: A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychol Med 2007; 37: 283–94 CrossRef MEDLINE
e69.Pols RG, Battersby MW: Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue. Med J Aust 2008; 188(12 Suppl): 133–7.
e70.van der Weijden T, van Velsen M, Dinant GJ, van Hasselt CM, Grol R: Unexplained complaints in general practice: prevalence, patients‘ expectations, and professionals‘ test-ordering behavior. Med Decis Making 2003; 23: 226–31 CrossRef MEDLINE
e71.Heijmans M, Olde Hartman TC, van Weel-Baumgarten E, Dowrick C, Lucassen PL, van Weel C: Experts‘ opinions on the management of medically unexplained symptoms in primary care. A qualitative analysis of narrative reviews and scientific editorials. Fam Pract 2011; 28: 444–55 CrossRef MEDLINE
e72.Fink P, Rosendal M, Toft T: Assessment and treatment of functional disorders in general practice: the extended reattribution and management model—an advanced educational program for nonpsychiatric doctors. Psychosomatics 2002; 43: 93–131 CrossRef MEDLINE
e73.Larisch A, Schweickhardt A, Wirsching M, Fritzsche K: Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. J Psychosom Res 2004; 57: 507–14 CrossRef MEDLINE
e74.Rief W, Martin A, Rauh E, Zech T, Bender A: Evaluation of general practitioners‘ training: how to manage patients with unexplained physical symptoms. Psychosomatics 2006; 47: 304–11 CrossRef MEDLINE
e75.Rosendal M, Olesen F, Fink P, Toft T, Sokolowski I, Bro F: A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. Gen Hosp Psychiatry 2007; 29: 364–73 CrossRef MEDLINE
e76.Smith RC, Gardiner JC, Luo Z, Schooley S, Lamerato L, Rost K: Primary care physicians treat somatization. J Gen Intern Med 2009; 24: 829–32 CrossRef MEDLINE PubMed Central
e77.Weiland A, Blankenstein AH, van Saase JL, et al.: Training medical specialists to communicate better with patients with Medically Unexplained Physical Symptoms (MUPS). A randomized, controlled trial. PLoS One 2015; 10: e0138342 CrossRef MEDLINE PubMed Central
e78.Warner A, Walters K, Lamahewa K, Buszewicz M: How do hospital doctors manage patients with medically unexplained symptoms: a qualitative study of physicians. J R Soc Med 2017; 110: 65–72 CrossRef MEDLINE PubMed Central
e79.Yon K, Habermann S, Rosenthal J, et al.: Improving teaching about medically unexplained symptoms for newly qualified doctors in the UK: findings from a questionnaire survey and expert workshop. BMJ Open 2017; 7: e014720 CrossRef MEDLINE PubMed Central
e80.Schaefert R, Benedikt G, Sauer N, et al.: Früherkennung und Behandlung funktioneller/somatoformer Beschwerden in der Allgemeinarztpraxis – das FUNKTIONAL-Forschungsprojekt. Notfall & Hausarztmedizin 2005; 31: 527–36 CrossRef
e81.Rudolf G, Henningsen P: Die psychotherapeutische Behandlung somatoformer Störungen. Z Psychsom Med Psychother 2003; 49: 3–19 CrossRef MEDLINE
e82.Langewitz W: Patientenzentrierte Kommunikation. In: Adler RH, Herzog W, Joraschky P, et al.: Psychosomatische Medizin. Theoretische Modelle und klinische Praxis. München: Elsevier, Urban & Fischer 2011: 338–47.
e83.Rolfe A, Burton C: Reassurance after diagnostic testing with a low pretest probability of serious disease: systematic review and meta-analysis. JAMA Intern Med 2013; 173: 407–16 CrossRef MEDLINE
e84.Kroenke K: Diagnostic testing and the illusory reassurance of normal results: comment on „Reassurance after diagnostic testing with a low pretest probability of serious disease“. JAMA Intern Med 2013; 173: 416–7 CrossRef MEDLINE
e85.Petrie KJ, Sherriff R: Normal diagnostic test results do not reassure patients. Evid Based Med 2014; 19: 14 CrossRef MEDLINE
e86.Widder B, Dertwinkel R, Egle UT, Foerster K, Schiltenwolf M: Leitlinie für die Begutachtung von Schmerzen. Psychotherapeut 2007; 52: 334–46 CrossRef
e87.Burton C, Lucassen P, Aamland A, Olde Hartman T: Explaining symptoms after negative tests: towards a rational explanation. J R Soc Med 2015; 108: 84–8 CrossRef MEDLINE PubMed Central
e88.Vedsted P, Christensen MB, Sørensen HT, Fink P, Olesen F: Special status consultation for frequent attenders. Who are the candidates? J Public Health Med 2002; 24: 53–7 CrossRef
e89.Fink P, Rosendal M, Toft T: Assessment and treatment of functional disorders in general practice: the extended reattribution and management model—an advanced educational program for nonpsychiatric doctors. Psychosomatics 2002; 43: 93–131 CrossRef MEDLINE
e90.Bahrs O: Der Bilanzierungsdialog. Der Mensch 2007; 38: 29–32.
e91.Stephens G, Derry S, Moore RA: Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev 2016; (6): CD011889 CrossRef MEDLINE PubMed Central
e92.Derry S, Wiffen PJ, Häuser W, et al.: Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults. Cochrane Database Syst Rev 2017; 3: CD012332 CrossRef PubMed Central
e93.Soares A, Andriolo RB, Atallah AN, da Silva EM: Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database Syst Rev 2014; (7): CD007533 CrossRef
e94.Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ: Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev 2014; (11): CD010628 CrossRef
e95.Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W: Antipsychotics for fibromyalgia in adults. Cochrane Database Syst Rev 2016; (6): CD011804 CrossRef PubMed Central
e96.Ford AC, Luthra P, Tack J, Boeckxstaens GE, Moayyedi P, Talley NJ: Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut 2017; 66: 411–20 CrossRef MEDLINE
e97.Moayyedi P, Quigley EM, Lacy BE, et al.: The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol 2014; 109: 1367 CrossRef MEDLINE
e98.Tiequn B, Guanqun C, Shuo Z: Therapeutic effects of lactobacillus in treating irritable bowel syndrome: a meta-analysis. Intern Med 2015; 54: 243–9 CrossRef MEDLINE
e99.Furlan AD, Giraldo M, Baskwill A, Irvin E, Imamura M: Massage for low-back pain. Cochrane Database Syst Rev 2015; (9): CD001929 CrossRef MEDLINE
e100.Naumann J, Sadaghiani C: Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: a qualitative systematic review and meta-analysis of randomized controlled trials. Arthritis Res Ther 2014; 16: R141 CrossRef MEDLINE PubMed Central
e101.Salazar AP, Stein C, Marchese RR, Plentz RD, Pagnussat AS: Electric stimulation for pain relief in patients with fibromyalgia: a systematic review and meta-analysis of randomized controlled trials. Pain Physician 2017; 20: 15–25.
e102.Müller A, Franke H, Resch KL, Fryer G: Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review. J Am Osteopath Assoc 2014; 114: 470–9 CrossRef MEDLINE
e103.Martins WR, Blasczyk JC, Aparecida Furlan de Oliveira M, Lagoa Goncalves KF, Bonini-Rocha AC, Dugailly PM: Efficacy of musculoskeletal manual approach in the treatment of temporomandibular joint disorder: a systematic review with meta-analysis. Man Ther 2016; 21: 10–7 CrossRef MEDLINE
e104.Mesa-Jiménez JA, Lozano-López C, Angulo-Díaz-Parreño S, Rodríguez-Fernández ÁL, De-la-Hoz-Aizpurua JL, Fernández-de-Las-Peñas C: Multimodal manual therapy vs. pharmacological care for management of tension type headache: a meta-analysis of randomized trials. Cephalalgia 2015; 35: 1323–32 CrossRef MEDLINE
e105.Lam M, Galvin R, Curry P: Effectiveness of acupuncture for nonspecificchronic low back pain: a systematic review and meta-analysis. Spine (Phila Pa1976) 2013; 38: 2124–38 CrossRef MEDLINE
e106.Ainpradub K, Sitthipornvorakul E, Janwantanakul P, van der Beek AJ: Effect of education on non-specific neck and low back pain: a meta-analysis of randomized controlled trials. Man Ther 2016; 22: 31–41 CrossRef MEDLINE
e107.Anheyer D, Haller H, Barth J, Lauche R, Dobos G, Cramer H: Mindfulness-based stress reduction for treating low back pain: a systematic review and meta-analysis. Ann Intern Med 2017; 166: 799–807 CrossRef MEDLINE
e108.Searle A, Spink M, Ho A, Chuter V: Exercise interventions for the treatment of chronic low back pain: a systematic review and meta-analysis of randomised controlled trials. Clin Rehabil 2015; 29: 1155–67 CrossRef MEDLINE
e109.Kamper SJ, Apeldoorn AT, Chiarotto A, et al.: Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev 2014; (9): CD000963 CrossRef MEDLINE
e110.Waterschoot FP, Dijkstra PU, Hollak N, de Vries HJ, Geertzen JH, Reneman MF: Dose or content? Effectiveness of pain rehabilitation programs for patients with chronic low back pain: a systematic review. Pain 2014; 155: 179–89 CrossRef MEDLINE
e111.van der Feltz-Cornelis CM, van Os TW, van Marwijk HW, Leentjens AF: Effect of psychiatric consultation models in primary care. A systematic review and meta-analysis of randomized clinical trials. J Psychosom Res 2010; 68: 521–33 CrossRef MEDLINE
e112.Hoedeman R, Blankenstein AH, van der Feltz‐Cornelis CM, Krol B, Stewart R, Groothoff JW: Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev 2010; (12): CD006524 CrossRef MEDLINE
e113.Koelen JA, Houtveen JH, Abbass A, et al.: Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry 2014; 204: 12–9 CrossRef MEDLINE
e114.Zech N, Hansen E, Bernardy K, Häuser W: Efficacy, acceptability and safety of guided imagery/hypnosis in fibromyalgia—a systematic review and meta-analysis of randomized controlled trials. Eur J Pain 2017; 21: 217–27 CrossRef MEDLINE
e115.van den Bergh O, Witthöft M, Petersen S, Brown RJ: Symptoms and the body: taking the inferential leap. Neurosci Biobehav Rev 2017; 74(Pt A): 185–203 CrossRef MEDLINE
e116.Varinen A, Kosunen E, Mattila K, Koskela T, Sumanen M: The relationship between childhood adversities and fibromyalgia in the general population. J Psychosom Res 2017; 99: 137–42 CrossRef MEDLINE
e117.Guthrie E: Adaptation of the psychodynamic-interpersonal model to work with medically unexplained symptoms. In: Barkham M, Guthrie E, Hardy GE, Margison F, eds.: Psychodynamic interpersonal therapy: a conversational model. London: Sage 2017.
e118.Probst T, von Heymann F, Zaudig M, et al.: Effektivität stationärer psychosomatischer Krankenhausbehandlung – Ergebnisse einer multizentrischen Katamnesestudie. Z Psychosom Med Psychother 2009; 55: 409–20 CrossRef MEDLINE
e119.Beutel ME, von Heymann F, Bleichner F, Tritt K, Hardt J: Wie wirksam ist psychosomatische Therapie bei somatoformen Störungen? Ergebnisse einer Multicenterstudie. Z Psychosom Med Psychother 2014; 60: 17–24 CrossRef MEDLINE